about
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patientsClinical utility of platinum chromium bare-metal stents in coronary heart diseaseStent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatmentEfficacy of Drug-Eluting Balloons for Patients With In-Stent Restenosis: A Meta-Analysis of 8 Randomized Controlled Trials.Optimal conjugation of catechol group onto hyaluronic acid in coronary stent substrate coating for the prevention of restenosis.Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosisAn effective approach to reduce inflammation and stenosis in carotid artery: polypyrrole nanoparticle-based photothermal therapy.In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications.Potential of modeling and simulations of bioengineered devices: Endoprostheses, prostheses and orthoses.Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent RestenosisLocal Anti-miR Delivery: The Latest in the Arsenal of Drug-Eluting Stents.Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosisDrug-coated balloons for the treatment of in-stent restenosis in diabetic patients: A review of currently available scientific data.Costs and clinical outcomes for non-invasive versus invasive diagnostic approaches to patients with suspected in-stent restenosis.Techniques in Vascular and Interventional Radiology Drug Delivery Technologies in the Superficial Femoral ArteryTreatment for in-stent restenosis: patient-specific decision rather than universal recommendationBiological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model.Covalent modification of pericardial patches for sustained rapamycin delivery inhibits venous neointimal hyperplasiaCoronary Bifurcation Intervention: What Role Do Bifurcation Angles Play?Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation.Treatment of coronary artery in-stent restenosis.Optimisation of percutaneous coronary intervention: indispensables for bioresorbable scaffolds.Drug-eluting balloons in coronary interventions: the quiet revolution?IVUS-Guided Implantation of Bioresorbable Vascular Scaffolds for Very Late Paclitaxel Stent Thrombosis.Neoatherosclerosis causing edge in-stent restenosis: optical coherence tomography findingsClinical outcomes following target lesion revascularization for bioresorbable scaffold failure.Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.Diagnosis and management challenges of in-stent restenosis in coronary arteries.Downregulation of Cavin-1 Expression via Increasing Caveolin-1 Degradation Prompts the Proliferation and Migration of Vascular Smooth Muscle Cells in Balloon Injury-Induced Neointimal Hyperplasia.Optimal interventional strategy for the treatment of coronary in-stent restenosis.Elevated Levels of Very Low-density Lipoprotein Cholesterol Independently Associated with In-stent Restenosis in Diabetic Patients after Drug-eluting Stent ImplantationDrug-eluting stent in-stent restenosis and re-restenosis: A hard time storyDrug-Coated Balloon Treatment of Very Late Stent Thrombosis Due to Complicated Neoatherosclerosis.Prognostic Value of Plasma Long Noncoding RNA ANRIL for In-Stent Restenosis.Network meta-analyses on in-stent restenosis treatment: dealing with complexity to clarify efficacy and safety.In-stent restenosis: local drug delivery with a stent or balloon?Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry.In-stent neoatherosclerosis and tissue characteristics of restenotic lesions following implantation of second generation drug-eluting stents in unrestricted coronary lesions: Optical frequency domain imaging study.Thirty-Day and One-Year Clinical Outcomes of Bioresorbable Vascular Scaffold Implantation: A Single-Center Experience.
P2860
Q26780172-391B9690-C49F-4B17-9520-9B46589828BEQ26783440-2A7CE967-DE4B-4551-A40A-4263A154AFC4Q26785321-177D94EC-ADFF-4F44-B75F-B907EA210264Q28073031-2BA20EF4-F131-4BBE-A741-31342364011EQ30252070-89F4DA53-F03F-4D3C-9A97-B82A842CE450Q31164958-7A1C443E-0FF7-45AE-819C-1F27CA110430Q33836997-F8A08DDD-C265-43E9-8180-71F01B3D44ACQ35592616-6555C159-162C-4B88-891D-2D1D6712EDA6Q35779631-1C8DA2A0-7757-4368-8F25-7F6327463561Q35994405-A3F2DD51-2711-4720-8033-DF17BBB29322Q36004612-0EC7DC25-56A3-49E1-9629-3A02C4C2492AQ36198491-F759314B-13E3-462D-85E3-2D240E415648Q36243208-843372BA-45CD-4215-97FF-2DD32E85D32FQ36381320-31FA479B-803A-4B3A-9F95-F477940E4D3DQ36540885-4CB00E33-AC24-4210-A1B8-36A4AAC031BDQ37102287-7683B8F3-8D16-41AD-87BE-6B8BDEC833AEQ37208755-D7D1BD0F-3CD1-453D-A6C4-82CCDAEFEAA3Q37337286-C5EDB131-C8BF-480A-A104-EDFC5520A50EQ37575912-B2C03DF2-9EA7-40DC-849A-673D5E83CD45Q38525049-E10E3021-F644-46A3-84DA-B77BCC1211EAQ38716001-FF7BA500-49DF-49FD-9343-60B1BB072BEBQ38766516-715B27D5-31B8-4E00-A6F6-CC488F3AB33AQ38885397-B29B58D8-D8F7-4BED-ACDD-0BD9325C2D78Q38975708-BECAF95D-C9EB-4548-AAD1-9FDAA66506AAQ39140488-DB018725-78E7-4EFB-80A0-ABFAB0C9BEB1Q39952700-BB875100-10B7-426C-8C30-BAFC2D938D70Q40582846-381CC024-AF88-4F1A-8925-DC80BA1C229FQ41420992-85FB03CC-235D-4DAA-A491-9FF5386FD029Q41608247-4C8524C3-22D4-447E-B38D-C6A662A9FC08Q41628232-F47F4E78-0C31-40B7-AE6A-710A05E80294Q41989523-0E3E849A-D4FD-4C61-9B88-6E55667DD963Q42267353-CE195255-79E6-4D75-B5A8-232102169D15Q42314283-1128F59A-E7C0-4050-962A-D75F8CA4183FQ42426278-DA053F9B-003F-4C29-B432-41D67371A29CQ42705467-91C32A97-D03A-4A81-96D3-13A52ECB29CFQ43185744-146EF17A-186C-4DAA-AD58-89BC40D1681CQ43185804-DDDF3D82-E641-4CD0-A9B3-F65EE586FEBCQ46093469-7A4473A5-92A2-4E6D-B8D4-D94A736C9F26Q46457233-32EF6C01-5A4E-4FD9-8583-F0A42B6857FAQ46586855-5DBCC9A1-6C75-4040-9895-CE1E81441A36
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current treatment of in-stent restenosis.
@en
type
label
Current treatment of in-stent restenosis.
@en
prefLabel
Current treatment of in-stent restenosis.
@en
P1476
Current treatment of in-stent restenosis.
@en
P2093
Adnan Kastrati
Fernando Alfonso
P304
P356
10.1016/J.JACC.2014.02.545
P407
P577
2014-03-13T00:00:00Z